01625nas a2200157   4500000000100000008004100001653003900042653003500081653001400116653001000130100001000140700001300150245006700163520122300230022001401453       2018                            d10aNeglected tropical diseases (NTDs)10aSoil-transmitted helminthiasis10aDeworming10aDrugs1 aLin W1 aAddiss D00aSustainable access to deworming drugs in a changing landscape.3 a<p>The global effort to control and eliminate soil-transmitted helminthiasis (STH) currently depends on donations of albendazole and mebendazole, which reached more than 530 million children in 2016. As we approach 2020, the WHO goal of eliminating STH as a public health problem will not be met in most endemic countries, and ongoing treatment will be necessary. Additionally, the volume of drugs required might increase because global strategies for STH aim to interrupt transmission. Under the 2012 London Declaration on Neglected Tropical Diseases, pharmaceutical company commitments to donate drugs to control or eliminate neglected tropical diseases extend to 2020. We are approaching a period of uncertainty regarding different strategies for control and elimination of STH, the size and target populations for future donations, and optimum drugs and drug combinations. Long-term reliance on large-scale donation of deworming drugs is not sustainable. The global STH community need to develop a strategy to secure a sustainable global supply of affordable and effective anthelmintic drugs. This strategy should include improvement of the quality of generic drugs through innovative technical partnerships.</p>
  a1474-4457